Northwest Technology Ventures

Adapx, Inc. is a software company based in Seattle, Washington, that specializes in user interface solutions designed to enhance data capture and integration for businesses and agencies. The company's primary offering, Capturx, enables users to convert natural speech, sketches, and handwriting into structured data for Microsoft Office and other backend systems. This solution helps streamline workflows by eliminating the need for data transcription and allows for efficient data collection through various mediums, including paper, touchscreens, and mobile devices. Adapx provides several tailored applications, such as Capturx for SharePoint, Capturx Forms for Excel, and Capturx for ArcGIS Desktop, among others. The company serves multiple industries, including manufacturing, defense, healthcare, and utilities. Additionally, Adapx has established strategic partnerships with major organizations like Microsoft and ESRI to enhance its product offerings. Founded in 1999, Adapx was previously known as Natural Interaction Systems.

Adapx, Inc. is a software company based in Seattle, Washington, that specializes in user interface solutions designed to enhance data capture and integration for businesses and agencies. The company's primary offering, Capturx, enables users to convert natural speech, sketches, and handwriting into structured data for Microsoft Office and other backend systems. This solution helps streamline workflows by eliminating the need for data transcription and allows for efficient data collection through various mediums, including paper, touchscreens, and mobile devices. Adapx provides several tailored applications, such as Capturx for SharePoint, Capturx Forms for Excel, and Capturx for ArcGIS Desktop, among others. The company serves multiple industries, including manufacturing, defense, healthcare, and utilities. Additionally, Adapx has established strategic partnerships with major organizations like Microsoft and ESRI to enhance its product offerings. Founded in 1999, Adapx was previously known as Natural Interaction Systems.

DesignMedix, Inc. is a drug development company based in Portland, Oregon, founded in 2006. The company specializes in creating small molecule drugs aimed at combating drug resistance in infectious diseases. Its lead candidate, DM1157, offers a potential cure for drug-resistant malaria, particularly benefiting vulnerable populations such as children and pregnant women. In addition to malaria, DesignMedix is developing drug candidates targeting trichomonas vaginalis, helicobacter pylori, and various bacterial and parasitic infections. The innovative approach employed by DesignMedix involves covalently linking a chemical moiety derived from resistance reversal agents, allowing these drugs to serve dual roles as both therapeutic and resistance-modifying agents. This strategy aims to simplify treatment protocols for medical practitioners dealing with these challenging infections.

Translarity is an innovator in the semiconductor wafer test industry, focused on the advanced probe card market. Headquartered in Silicon Valley, Translarity brings a disruptive change to the world of semiconductor test by offering a full-wafer test with low cost, high performance, and short cycle time. Translarity acquired BucklingBeam in 2017 to expand its offerings and deliver a full suite of probe card solutions, including full probe cards and vertical probe head solutions. Combined with the company’s advanced Space Translator™ space transformer technology, the company addresses the rapid state of acceleration in probe technologies. Translarity’s proven management team, backed by strong financial investors, recruited a dynamic team of top industry talent to address the unmet challenges in building the Wafer Translator™ technology. In creating the Translarity solution, the team developed a fertile innovation pipeline and a strong IP portfolio, with more than 45 patents already issued and more than 50 filed.

AboutUs is a freely editable wiki that focuses on small businesses, organizations, and websites. It uses Ruby on Rails.

Receptor Biologix develops receptor-based biological therapeutics for cancer, inflammatory, and autoimmune diseases. The company is headquartered in Palo Alto, California.

Artielle ImmunoTherapeutics, Inc. is a biopharmaceutical company based in Tigard, Oregon, that develops biologic drugs aimed at treating inflammatory and degenerative diseases. Founded in 2004, the company specializes in therapies for neuro-inflammatory conditions such as multiple sclerosis, optic neuritis, and stroke, as well as autoimmune diseases like rheumatoid arthritis, celiac disease, and type 1 diabetes. Artielle's primary focus includes the development of recombinant T-cell receptor ligands (RTLs), specifically RTL1000 for multiple sclerosis, which target the CD74 receptor on monocytes to inhibit the action of macrophage migration inhibitory factor. Through its innovative platform, Artielle aims to address significant unmet medical needs in the treatment of various debilitating conditions.

IP Fabrics, Inc. is a provider of network visibility, compliance, and analytics solutions for various sectors, including telecommunications, cable, wireless, and government agencies. Headquartered in Beaverton, Oregon, the company offers a range of products designed for network surveillance and diagnostics. Key offerings include TunnelBox, which facilitates remote traffic access for diagnostics and compliance; DeepProbe, a tool for deep packet inspection and real-time alerts; and DeepSweep, which supports lawful intercept compliance and network visibility. Additionally, CyberInsight provides analytics for network behavior analysis and forensics. IP Fabrics also supplies development services, training, maintenance, and support for its products. Founded in 2002, the company has established a diverse customer base, including surveillance providers, law enforcement, and service operators, and operates as a subsidiary of Yaana Technologies, LLC.

Ambric developed a massively parallel processor array integrated circuit for high performance applications. Ambric's parallel processor solution including a "structured object programming model" that allowed developers to effectively program the large number of cores. Ambric's first generation chip architecture, Am2045, featured 336 processors on a chip. It competed against large FPGA's, DSPs and use of Intel x86 processors used in embedded markets. Ambric targeted video compression markets, medical imaging, wireless basesation and military markets.